The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: risperdal consta     Quarter: 2016Q3

Total Records: 310     Number of Pages: 16

DRUGNAME PT EventCount
RISPERDAL CONSTA Balance disorder 2
RISPERDAL CONSTA Blood cholesterol decreased 2
RISPERDAL CONSTA Blood cholesterol increased 2
RISPERDAL CONSTA Blood sodium increased 2
RISPERDAL CONSTA Blood triglycerides increased 2
RISPERDAL CONSTA Blood urea decreased 2
RISPERDAL CONSTA Bundle branch block left 2
RISPERDAL CONSTA Cardiac septal hypertrophy 2
RISPERDAL CONSTA Confusional state 2
RISPERDAL CONSTA Congestive cardiomyopathy 2
RISPERDAL CONSTA Constipation 2
RISPERDAL CONSTA Coronary artery disease 2
RISPERDAL CONSTA Cyanosis 2
RISPERDAL CONSTA Defect conduction intraventricular 2
RISPERDAL CONSTA Dehydration 2
RISPERDAL CONSTA Diarrhoea 2
RISPERDAL CONSTA Diastolic dysfunction 2
RISPERDAL CONSTA Disorientation 2
RISPERDAL CONSTA Dysphagia 2
RISPERDAL CONSTA Dysuria 2

Total Records: 310     Number of Pages: 16